BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22912742)

  • 41. Neuregulin receptors erbB2 and erbB4 in failing human myocardium -- depressed expression and attenuated activation.
    Rohrbach S; Niemann B; Silber RE; Holtz J
    Basic Res Cardiol; 2005 May; 100(3):240-9. PubMed ID: 15685397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish.
    Becker JR; Deo RC; Werdich AA; Panàkovà D; Coy S; MacRae CA
    Dis Model Mech; 2011 May; 4(3):400-10. PubMed ID: 21245263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosis.
    Scotland RL; Allen L; Hennings LJ; Post GR; Post SR
    PLoS One; 2013; 8(9):e73599. PubMed ID: 24069211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
    Fu Y; Westenbroek RE; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16598-603. PubMed ID: 25368181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
    Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
    J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
    Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
    Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.
    McMullen JR; Amirahmadi F; Woodcock EA; Schinke-Braun M; Bouwman RD; Hewitt KA; Mollica JP; Zhang L; Zhang Y; Shioi T; Buerger A; Izumo S; Jay PY; Jennings GL
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):612-7. PubMed ID: 17202264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of mammalian target of rapamycin with rapamycin reverses hypertrophic cardiomyopathy in mice with cardiomyocyte-specific knockout of PTEN.
    Xu X; Roe ND; Weiser-Evans MC; Ren J
    Hypertension; 2014 Apr; 63(4):729-39. PubMed ID: 24446058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
    Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W; Bisi J; Strum J; Liu L; Carrick K; Graham KM; Treece AL; Hardwicke MA; Dush M; Liao Q; Westlund RE; Zhao S; Bacus S; Spector NL
    Cancer Res; 2006 Feb; 66(3):1640-7. PubMed ID: 16452223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
    Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of cardiac stress signaling by protein kinase d1.
    Harrison BC; Kim MS; van Rooij E; Plato CF; Papst PJ; Vega RB; McAnally JA; Richardson JA; Bassel-Duby R; Olson EN; McKinsey TA
    Mol Cell Biol; 2006 May; 26(10):3875-88. PubMed ID: 16648482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction.
    Rajagopalan V; Zucker IH; Jones JA; Carlson M; Ma YJ
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H543-54. PubMed ID: 18599591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy.
    Lorén CE; Dahl CP; Do L; Almaas VM; Geiran OR; Mörner S; Hellman U
    Cells; 2019 Jan; 8(2):. PubMed ID: 30699940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
    Awasthi S; Ezelle H; Hassel BA; Hamburger AW
    Mol Cell Biochem; 2015 Jul; 405(1-2):177-86. PubMed ID: 25876877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.